Neuropsychopharmacology Research Group

• Silva V.L.M.; Silva A.M.S.; Pinto D.C.G.A.; Jagerovic N.; Callado L.F.; Cavaleiro J.A.S.; Elguero J  Synthesis and pharmacological evaluation of chlorinated N-Alkyl-3-and -5-(2-hydroxyphenyl)pyrazoles as CB1 cannabinoid ligands Monatshefte für Chemie,  2007;  138,  797 - 811
• Ballesteros J, Callado LF, Gutiérrez M. J  An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder Journal of Clinical Psychopharmacology,  2007;  27(2),  219 - 221
• Rodriguez F, Rozas I, Ortega JE, Meana JJ, Callado LF.  Guanidine and 2-aminoimidazoline aromatic derivatives as alpha(2)-adrenoceptor antagonists, 1: toward new antidepressants with heteroatomic linkers Journal of Medicinal Chemistry,  2007;  50(18),  4516 - 4527
• Corcoran J, Rodriguez F, Rozas I, Meana JJ, Callado LF.  On the search of new I2-IBS aliphatic ligands: bis-guanidino carbonyl derivatives Bioorganic & Medicinal Chemistry Letters,  2007;  17(21),  6009 - 6012